STOCK TITAN

NHC (NYSE: NHC) CIO awarded 14,000 stock options vesting through 2029

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

FLATT BEN ANDERSON SR reported acquisition or exercise transactions in this Form 4 filing.

National Healthcare Corp senior vice president and CIO Ben Anderson Flatt Sr reported an equity award of stock options. On February 23, 2026, he received options to purchase 14,000 shares of common stock under the 2020 Omnibus Equity Incentive Plan.

These options vest in three equal installments: one‑third on February 23, 2027, one‑third on February 23, 2028, and the final one‑third on February 23, 2029. The award is structured as long‑term incentive compensation rather than an open‑market share purchase.

Positive

  • None.

Negative

  • None.
Insider FLATT BEN ANDERSON SR
Role Senior VP & CIO
Type Security Shares Price Value
Grant/Award Option to Purchase Common Stock 14,000 $0.00 --
holding Option to Purchase Common Stock -- -- --
holding Option to Purchase Common Stock -- -- --
holding Option to Purchase Common Stock -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Option to Purchase Common Stock — 14,000 shares (Direct); Common Stock — 14,117.055 shares (Direct)
Footnotes (1)
  1. These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 23, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). These stock options will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 23, 2027; one-third (1/3) will vest on February 23, 2028; and the final one-third (1/3) will vest on February 23, 2029.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
FLATT BEN ANDERSON SR

(Last) (First) (Middle)
100 VINE STREET

(Street)
MURFREESBORO TN 37130

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
NATIONAL HEALTHCARE CORP [ NHC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Senior VP & CIO
3. Date of Earliest Transaction (Month/Day/Year)
02/23/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 14,117.0547 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Option to Purchase Common Stock $53.94 03/08/2024 03/08/2028 Common Stock 7,467 7,467 D
Option to Purchase Common Stock $94.1 03/05/2025 03/05/2029 Common Stock 12,000 12,000 D
Option to Purchase Common Stock $90.62 02/24/2026 02/24/2030 Common Stock 13,500 13,500 D
Option to Purchase Common Stock $157.13 02/23/2026 A 14,000(1) 02/24/2027(2) 02/24/2031 Common Stock 14,000 $0 14,000 D
Explanation of Responses:
1. These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 23, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
2. These stock options will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 23, 2027; one-third (1/3) will vest on February 23, 2028; and the final one-third (1/3) will vest on February 23, 2029.
/s/ Ben Anderson Flatt 02/25/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did NHC report for Ben Anderson Flatt Sr?

National Healthcare Corp reported that senior VP and CIO Ben Anderson Flatt Sr received stock options to purchase 14,000 shares of common stock. The options were granted on February 23, 2026 under the company’s 2020 Omnibus Equity Incentive Plan as equity-based compensation.

How many NHC stock options were granted in this Form 4 filing?

The Form 4 shows a grant of stock options covering 14,000 shares of National Healthcare Corp common stock. This equity award was issued to senior VP and CIO Ben Anderson Flatt Sr as part of long-term incentive compensation, rather than a market purchase of existing shares.

When do Ben Anderson Flatt Sr’s NHC stock options vest?

These NHC stock options vest ratably over three years. One‑third of the 14,000 options vest on February 23, 2027, another third on February 23, 2028, and the final third on February 23, 2029, aligning vesting with multi‑year service.

Under which plan were the NHC stock options granted to the executive?

The stock options reported for Ben Anderson Flatt Sr were granted under National Healthcare Corp’s 2020 Omnibus Equity Incentive Plan. This plan provides equity-based awards, such as options, to executives and employees as part of their compensation structure and long-term incentives.

Is the NHC insider transaction a stock purchase or an option grant?

The transaction is an option grant, not an open-market stock purchase. Ben Anderson Flatt Sr received options to buy 14,000 NHC shares in the future, subject to a three‑year vesting schedule ending on February 23, 2029, under the equity incentive plan.

Who is the insider involved in this NHC Form 4 filing?

The insider is Ben Anderson Flatt Sr, who serves as senior vice president and chief information officer of National Healthcare Corp. The Form 4 records his receipt of stock options for 14,000 shares of company common stock as an equity award.